Food, Drugs, Healthcare, Life Sciences

On November 7, Vera Therapeutics announced that it submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) through the Accelerated Approval Program for atacicept for the treatment...

In the Continuing Resolution and Appropriations Package (H.R. 5371), enacted into law on November 12, 2025, Congress included several new provisions regarding over-the-counter (OTC) drug and sunscreen products.

Rare and ultra-rare disease product developers face numerous complexities, including in designing and executing clinical trials in very small patient populations, defining and validating endpoints, satisfying the statutory evidentiary standard for product approval, and attracting investment for products with uncertain trajectories.

Growing interest in sustainable agriculture has increased demand for plant biostimulant products that enhance natural plant processes to improve crop performance. In general, plant biostimulant products refer to biological...

The U.S. Patent and Trademark Office (USPTO) has implemented a Continuation Application Fee (CAF) for certain continuing applications filed more than six or nine years after their earliest benefit date.

Rare and ultra-rare disease product developers face numerous complexities, including in designing and executing clinical trials in very small patient populations, defining and validating endpoints, satisfying the statutory evidentiary standard for product approval, and attracting investment for products with uncertain trajectories.

Each week while Congress is in session, our Policy team delivers a key update to highlight a topical benefits, health, or retirement news item from the Hill, such as a newly introduced bill, a summary of a committee...

Many people believe they've already taken care of their medical directive simply because they've completed one through their health insurer—often Kaiser Permanente here in California.

For patients and providers alike, prior authorization remains one of the most persistent pain points in healthcare.